Yuying Gao

Shanghai, 201306, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

CS-DES-OEO hot-pressed films with improved heat-sealing strength and antimicrobial activity for white bread preservation.

CS-DES-OEO hot-pressed films with improved heat-sealing strength and antimicrobial activity for white bread preservation.

Journal: Food chemistry

Published: April 14, 2026

Population Pharmacokinetics of Serplulimab and Quantitative Assessment of Transitioning From Weight-Based to Flat-Dosing Strategy.

Population Pharmacokinetics of Serplulimab and Quantitative Assessment of Transitioning From Weight-Based to Flat-Dosing Strategy.

Journal: CPT: pharmacometrics & systems pharmacology

Published: November 27, 2025

Bacterial cellulose: Modification and application in food packaging.

Bacterial cellulose: Modification and application in food packaging.

Journal: Carbohydrate polymers

Published: July 30, 2025

Population Pharmacokinetics and Exposure-Response Analysis of Serplulimab in Small Cell Lung Cancer Patients.

Population Pharmacokinetics and Exposure-Response Analysis of Serplulimab in Small Cell Lung Cancer Patients.

Journal: Clinical and translational science

Published: May 20, 2025

Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model-Based Approach.

Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model-Based Approach.

Journal: Clinical and translational science

Published: January 07, 2025

Deep eutectic solvent: Synthesis, classification, properties and application in macromolecular substances.

Deep eutectic solvent: Synthesis, classification, properties and application in macromolecular substances.

Journal: International journal of biological macromolecules

Published: May 11, 2024

Evaluation of omadacycline dosing regimens in Chinese using population pharmacokinetic-pharmacodynamic analysis.

Evaluation of omadacycline dosing regimens in Chinese using population pharmacokinetic-pharmacodynamic analysis.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: October 23, 2023

Clinical dose rationale of tislelizumab in patients with solid or hematological advanced tumors.

Clinical dose rationale of tislelizumab in patients with solid or hematological advanced tumors.

Journal: Clinical and translational science

Published: September 29, 2023

Model-based population pharmacokinetic analysis of tislelizumab in patients with advanced tumors.

Model-based population pharmacokinetic analysis of tislelizumab in patients with advanced tumors.

Journal: CPT: pharmacometrics & systems pharmacology

Published: June 01, 2022

Rationale for once-daily or twice-daily dosing of zanubrutinib in patients with mantle cell lymphoma.

Rationale for once-daily or twice-daily dosing of zanubrutinib in patients with mantle cell lymphoma.

Journal: Leukemia & lymphoma

Published: June 23, 2021

Covariate effects and population pharmacokinetic analysis of the anti-FGFR2b antibody bemarituzumab in patients from phase 1 to phase 2 trials.

Covariate effects and population pharmacokinetic analysis of the anti-FGFR2b antibody bemarituzumab in patients from phase 1 to phase 2 trials.

Journal: Cancer chemotherapy and pharmacology

Published: April 16, 2021

Pharmacokinetics and Exposure-Response Relationship of Teprotumumab, an Insulin-Like Growth Factor-1 Receptor-Blocking Antibody, in Thyroid Eye Disease.

Pharmacokinetics and Exposure-Response Relationship of Teprotumumab, an Insulin-Like Growth Factor-1 Receptor-Blocking Antibody, in Thyroid Eye Disease.

Journal: Clinical pharmacokinetics

Published: February 10, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026